Aptevo Therapeutics Inc. Basic Shares Outstanding (Weighted Average)
Aptevo Therapeutics Inc. (APVO) reported Basic Shares Outstanding (Weighted Average) of 1.20 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 1.20M shares, a 2817.39% increase year-over-year.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 1.06M shares, a 26083.12% increase year-over-year.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -4.42M shares.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 4.05M shares, a 28306.38% increase year-over-year.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 315.54K shares, a 41038.85% increase from fiscal 2024.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 767.00 shares, a 89.79% decline from fiscal 2023.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 7.51K shares, a 99.85% decline from fiscal 2022.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 5.10M shares, a 8.80% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.20M shares 10-Q · filed 2026-08-14 | 1.18M shares 10-Q · filed 2026-08-14 | -722.43K shares derived: average of 3 quarters · filed 2026-08-14 | 470.44K shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 1.06M shares 10-Q · filed 2026-05-13 | -1.68M shares derived: average of 2 quarters · filed 2026-05-13 | 228.46K shares derived: average of 3 quarters · filed 2026-05-13 | 181.60K shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -4.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -187.65K shares derived: average of 2 quarters · filed 2026-03-26 | -111.43K shares derived: average of 3 quarters · filed 2026-08-14 | 315.54K shares 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | 4.05M shares 10-Q · filed 2025-11-06 | 2.05M shares derived: average of 2 quarters · filed 2026-08-14 | 1.90M shares 10-Q · filed 2025-11-06 | 1.02M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 41.01K shares 10-Q · filed 2026-08-14 | 738.15K shares 10-Q · filed 2025-08-11 | 22.72K shares 10-Q · filed 2026-08-14 | 408.99K shares 10-Q · filed 2025-08-11 | 11.24K shares derived: average of 3 quarters · filed 2026-08-14 | 11.99K shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 4.05K shares 10-Q · filed 2026-05-13 | 1.46M shares 10-Q · filed 2025-05-15 | -3.65K shares derived: average of 2 quarters · filed 2026-05-13 | 2.32K shares derived: average of 3 quarters · filed 2026-05-13 | 2.93K shares derived: average of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -11.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 1.46K shares derived: average of 2 quarters · filed 2026-03-26 | 2.56K shares derived: average of 3 quarters · filed 2026-03-26 | 767.00 shares 10-K · filed 2026-03-26 | 276.14K shares 10-K · filed 2025-02-14 | |||
| 2024-09-30 | 14.25K shares 10-Q · filed 2025-11-06 | 10.55M shares 10-Q · filed 2024-11-07 | 9.51K shares derived: average of 2 quarters · filed 2025-11-06 | 4.80K shares 10-Q · filed 2025-11-06 | 3.55M shares 10-Q · filed 2024-11-07 | -136.61K shares derived: average of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | 4.76K shares 10-Q · filed 2025-08-11 | 3.52M shares 10-Q · filed 2024-08-08 | 2.85K shares 10-Q · filed 2025-08-11 | 2.11M shares 10-Q · filed 2024-08-08 | -186.90K shares derived: average of 3 quarters · filed 2025-08-11 | -68.70K shares derived: average of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | 18.56K shares 10-Q · filed 2025-05-15 | 686.74K shares 10-Q · filed 2024-05-08 | -282.73K shares derived: average of 2 quarters · filed 2025-05-15 | -93.19K shares derived: average of 3 quarters · filed 2025-05-15 | -33.06K shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -584.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -149.07K shares derived: average of 2 quarters · filed 2025-02-14 | -50.27K shares derived: average of 3 quarters · filed 2025-02-14 | 7.51K shares 10-K · filed 2025-02-14 | 12.23M shares 10-K · filed 2024-03-05 | |||
| 2023-09-30 | 285.89K shares 10-Q · filed 2024-11-07 | 12.58M shares 10-Q · filed 2023-11-14 | 216.60K shares derived: average of 2 quarters · filed 2024-11-07 | 204.69K shares 10-Q · filed 2024-11-07 | 9.01M shares 10-Q · filed 2023-11-14 | 1.49M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 147.32K shares 10-Q · filed 2024-08-08 | 6.48M shares 10-Q · filed 2023-08-10 | 163.43K shares 10-Q · filed 2024-08-08 | 7.19M shares 10-Q · filed 2023-08-10 | 1.88M shares derived: average of 3 quarters · filed 2024-08-08 | 2.69M shares derived: average of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | 159.60K shares 10-Q · filed 2024-05-08 | 7.02M shares 10-Q · filed 2023-05-11 | 2.75M shares derived: average of 2 quarters · filed 2024-05-08 | 3.53M shares derived: average of 3 quarters · filed 2024-05-08 | 3.91M shares derived: average of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | 5.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 5.22M shares derived: average of 2 quarters · filed 2024-03-05 | 5.15M shares derived: average of 3 quarters · filed 2024-03-05 | 5.10M shares 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | 5.09M shares 10-Q · filed 2023-11-14 | 5.06M shares derived: average of 2 quarters · filed 2023-11-14 | 5.02M shares 10-Q · filed 2023-11-14 | 5.02M shares 10-Q · filed 2022-11-10 | 4.99M shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | 5.02M shares 10-Q · filed 2023-08-10 | 4.98M shares 10-Q · filed 2023-08-10 | 4.95M shares derived: average of 3 quarters · filed 2023-08-10 | 4.94M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 4.94M shares 10-Q · filed 2023-05-11 | 4.92M shares derived: average of 2 quarters · filed 2023-05-11 | 4.91M shares derived: average of 3 quarters · filed 2023-05-11 | 4.82M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 4.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 4.90M shares derived: average of 2 quarters · filed 2023-03-30 | 4.78M shares derived: average of 3 quarters · filed 2023-03-30 | 4.69M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 4.89M shares 10-Q · filed 2022-11-10 | 4.71M shares derived: average of 2 quarters · filed 2022-11-10 | 4.62M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 4.54M shares 10-Q · filed 2022-08-11 | 4.48M shares 10-Q · filed 2022-08-11 | ||||||
| 2018-09-30 | 22.67M shares 10-Q · filed 2018-11-14 | 22.63M shares derived: average of 2 quarters · filed 2018-11-14 | 22.43M shares 10-Q · filed 2018-11-14 | |||||
| 2018-06-30 | 22.59M shares 10-Q · filed 2018-08-09 | 22.31M shares 10-Q · filed 2018-08-09 | ||||||
| 2018-03-31 | 22.03M shares 10-Q · filed 2018-05-10 | |||||||
| 2017-09-30 | 21.39M shares 10-Q · filed 2018-11-14 | 21.33M shares derived: average of 2 quarters · filed 2018-11-14 | 21.14M shares 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | 21.27M shares 10-Q · filed 2018-08-09 | 21.01M shares 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | 20.76M shares 10-Q · filed 2018-05-10 | |||||||
| 2016-09-30 | 20.24M shares 10-Q · filed 2017-11-13 | 20.23M shares 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |